Negar Pourjamal
Helsinki, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Combining an anti-HER2 antibody-drug conjugate with an anti-nectin-4 antibody-drug conjugate enhances efficacy in breast cancer and gastric cancer models.
Journal: Cancer cell international
Published: July 04, 2025
A Multicenter Randomized Controlled Trial of Antimicrobial Prophylaxis to Prevent Urinary Tract Infections after Shockwave Lithotripsy for Urolithiasis: The APPEAL Trial.
Journal: European urology
Published: June 29, 2025
Disitamab vedotin in preclinical models of HER2-positive breast and gastric cancers resistant to trastuzumab emtansine and trastuzumab deruxtecan.
Journal: Translational oncology
Published: September 20, 2024
Short- and long-term effects of imatinib in hospitalized COVID-19 patients: A randomized trial.
Journal: The Journal of infection
Published: February 19, 2024
Comparison of trastuzumab emtansine, trastuzumab deruxtecan, and disitamab vedotin in a multiresistant HER2-positive breast cancer lung metastasis model.
Journal: Clinical & experimental metastasis
Published: August 14, 2023
Systematic Reviews and Meta-analyses of the Procedure-specific Risks of Thrombosis and Bleeding in General Abdominal, Colorectal, Upper Gastrointestinal, and Hepatopancreatobiliary Surgery.
Journal: Annals of surgery
Published: August 08, 2023
Risk of thrombosis and bleeding in gynecologic cancer surgery: systematic review and meta-analysis.
Journal: American journal of obstetrics and gynecology
Published: May 04, 2023
Timing of symptomatic venous thromboembolism after surgery: meta-analysis.
Journal: The British journal of surgery
Published: November 15, 2022
Last Updated: 09/26/2026